CERT | tickerfilter.com

Fundamental analysis

27%

Profitability 0%

Dept financing 23%

Liquidity 75%

Performance 43%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.95%

1 Month

-15.37%

3 Months

3.17%

6 Months

6.83%

1 Year

-38.33%

2 Year

-42.27%

Key data

Stock price

$11.73

P/E Ratio

0.00

DAY RANGE

$11.13 - $11.95

EPS

-$0.08

52 WEEK RANGE

$9.41 - $19.29

52 WEEK CHANGE

-$37.74

MARKET CAP

1.714 B

YIELD

N/A

SHARES OUTSTANDING

160.889 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

1.43

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,501,757

AVERAGE 30 VOLUME

$1,418,358

Company detail

CEO: William F. Feehery
Region: US
Website: certara.com
Employees: 350
IPO year: 2020

Issue type: Common Stock
Market: XNAS
Industry: Computer Software/Services – Computer Programming And Data Processing
Sector: Services

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. The company also provides related technology- enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

CERT - Certara, Inc.